INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
MM

Manning Meredith

Chief Commercial OfficerCIK 0001752631

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells0 / 3
Max Insider Score33
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
33
MM
Manning MeredithChief Commercial Officer
SLNOSOLENO THERAPEUTICS INC
Open-market sale
SELL$146K
4,864 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    SOLENO THERAPEUTICS INCChief Commercial Officer · Jan 23, 2026
29
MM
Manning MeredithChief Commercial Officer
SLNOSOLENO THERAPEUTICS INC
Open-market sale
SELL
$65K
2,100 sh
Mar 27, 2026
Mar 31, 2026
traded Mar 27, 2026
+4d
SEC FORM 4

Evidence

26
MM
Manning MeredithChief Commercial Officer
SLNOSOLENO THERAPEUTICS INC
Open-market sale
SELL$18K
558 sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC FORM 4

Evidence

21
MM
Manning MeredithChief Commercial Officer
SLNOSOLENO THERAPEUTICS INC
Grant or award
A—
28.6K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence

9
MM
Manning MeredithChief Commercial Officer
SLNOSOLENO THERAPEUTICS INC
Grant or award
A—
32.8K sh
Jan 21, 2026Jan 23, 2026
traded Jan 21, 2026
+2dSEC FORM 4

Evidence